BRIEF-Glaxosmithkline Says FDA Approves Expanded Indication For Trelegy Ellipta In The U.S.
April 24 (Reuters) - GlaxoSmithKline:
* FDA APPROVED EXPANDED INDICATION FOR TRELEGY ELLIPTA IN THE U.S. FOR TREATMENT OF PATIENTS WITH COPD Source text for Eikon: Further company coverage: